HOUSE_OVERSIGHT_015496.jpg

1.67 MB
View Original

Extraction Summary

4
People
2
Organizations
1
Locations
2
Events
1
Relationships
3
Quotes

Document Information

Type: Magazine article / investigative file
File Size: 1.67 MB
Summary

A magazine article page (p. 36) titled 'An Unlikely Cure Signals New Hope for Cancer' by Kat McGowan. It details a case study at Memorial Sloan-Kettering where a 73-year-old bladder cancer patient ('Patient 45') had a miraculous recovery using the drug everolimus in 2010. The article highlights Dr. David Solit's work in sequencing the patient's genome to identify the mutations responsible for the cure. The document includes a Bates stamp 'HOUSE_OVERSIGHT_015496', indicating it is part of a congressional investigation file.

People (4)

Name Role Context
Kat McGowan Author
Author of the article regarding cancer research.
David Solit Clinical Oncologist / Director
Director of developmental therapeutics at Sloan-Kettering; sequenced the genome of the patient's cancer.
Patient Number 45 Patient
73-year-old woman with metastatic bladder cancer who was cured by everolimus.
Ellen Weinstein Illustrator
Credited for the illustration in the article.

Organizations (2)

Name Type Context
Memorial Sloan-Kettering Cancer Center
Location of the drug trial and research.
House Oversight Committee
Implied by the Bates stamp 'HOUSE_OVERSIGHT_015496'.

Timeline (2 events)

April 2010
Patient number 45's cancer was confirmed gone.
Sloan-Kettering
January 2010
Patient number 45 enrolled in the everolimus study at Sloan-Kettering.
Sloan-Kettering

Locations (1)

Location Context
Medical center where the study took place (New York).

Relationships (1)

David Solit Doctor-Patient/Researcher-Subject Patient Number 45
Solit analyzed the patient's genetic code to understand her reaction to the drug.

Key Quotes (3)

"In April 2010, her cancer was gone."
Source
HOUSE_OVERSIGHT_015496.jpg
Quote #1
"But this time was different. Clinical oncologist David Solit... saw a new opportunity to explain what happened by sequencing the whole genome of the woman’s cancer."
Source
HOUSE_OVERSIGHT_015496.jpg
Quote #2
"He found that one of her mutations shows up in about 8 to 10 percent of other bladder cancer patients"
Source
HOUSE_OVERSIGHT_015496.jpg
Quote #3

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document